US 11851477
DNA monoclonal antibodies targeting influenza virus
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 11851477 (DNA monoclonal antibodies targeting influenza virus) held by Inovio Pharmaceuticals, Inc. expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61P, A61P31/16